Dogwood Therapeutics, Inc.
DWTX
$4.99
-$0.07-1.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.34M | 9.72M | 8.70M | 4.31M | 3.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.20M | 15.34M | 12.23M | 5.82M | 4.80M |
| Operating Income | -18.20M | -15.34M | -12.23M | -5.82M | -4.80M |
| Income Before Tax | -24.55M | -21.79M | -12.35M | -5.73M | -4.68M |
| Income Tax Expenses | 190.10K | 190.00K | -500.00 | -- | -- |
| Earnings from Continuing Operations | -24.74 | -21.98 | -12.35 | -5.73 | -4.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.74M | -21.98M | -12.35M | -5.73M | -4.68M |
| EBIT | -18.20M | -15.34M | -12.23M | -5.82M | -4.80M |
| EBITDA | -15.86M | -11.95M | -7.54M | -- | -- |
| EPS Basic | -18.79 | -17.94 | -11.17 | -6.31 | -5.87 |
| Normalized Basic EPS | -8.21 | -7.68 | -6.73 | -3.94 | -3.67 |
| EPS Diluted | -18.79 | -17.94 | -11.17 | -6.31 | -5.87 |
| Normalized Diluted EPS | -8.21 | -7.68 | -6.73 | -3.94 | -3.67 |
| Average Basic Shares Outstanding | 5.77M | 4.78M | 4.11M | 3.57M | 3.22M |
| Average Diluted Shares Outstanding | 5.77M | 4.78M | 4.11M | 3.57M | 3.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |